3,4,5-trihydroxycinnamic acid

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

1.	Sepsis (Septicemia) 01/01/2020 - "How 3,4,5-Trihydroxycinnamic Acid Targets Vascular Leakage: Potential Targeted Sepsis Treatment." 05/01/2023 - "Previously, anti-inflammatory properties of 3,4,5-Trihydroxycinnamic acid (THC) has been reported in lipopolysaccharide (LPS)-induced RAW264.7 murine macrophage cells and in an LPS-induced sepsis BALB/c mice animal model. "
2.	Neoplasms (Cancer) 07/01/2019 - "Among the compounds examined, 3,4,5-trihydroxycinnamic acid decyl ester (6) showed the most potent inhibition of cancer cell growth by the induction of apoptosis. " 01/01/2013 - "3,4,5-Trihydroxycinnamic acid (THC) is a derivative of hydroxycinnamic acids, which have been reported to possess a variety of biological properties such as anti-inflammatory, anti-tumor, and neuroprotective activities. "
3.	Acute Lung Injury 11/01/2018 - "3,4,5-Trihydroxycinnamic acid attenuates lipopolysaccharide (LPS)-induced acute lung injury via downregulating inflammatory molecules and upregulating HO-1/AMPK activation."
4.	Chronic Obstructive Pulmonary Disease (COPD) 08/01/2020 - "3,4,5-Trihydroxycinnamic acid exerts a protective effect on pulmonary inflammation in an experimental animal model of COPD."
5.	Endotoxemia 05/01/2014 - "3,4,5-trihydroxycinnamic acid inhibits lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation in vitro and improves survival of mice in LPS-induced endotoxemia model in vivo."